223 related articles for article (PubMed ID: 23138970)
1. Chronic lung allograft dysfunction after lung transplantation: the moving target.
Sato M
Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):67-78. PubMed ID: 23138970
[TBL] [Abstract][Full Text] [Related]
2. Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation.
Matsubara K; Otani S; Yamamoto H; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
Surg Today; 2024 Apr; 54(4):317-324. PubMed ID: 37523071
[TBL] [Abstract][Full Text] [Related]
3. Restrictive allograft syndrome vs bronchiolitis obliterans syndrome: Immunological and molecular characterization of circulating exosomes.
Bansal S; Arjuna A; Perincheri S; Poulson C; Bremner RM; Smith MA; Tokman S; Mohanakumar T
J Heart Lung Transplant; 2022 Jan; 41(1):24-33. PubMed ID: 34602310
[TBL] [Abstract][Full Text] [Related]
4. Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.
Weigt SS; DerHovanessian A; Wallace WD; Lynch JP; Belperio JA
Semin Respir Crit Care Med; 2013 Jun; 34(3):336-51. PubMed ID: 23821508
[TBL] [Abstract][Full Text] [Related]
5. Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction.
Wong W; Johnson B; Cheng PC; Josephson MB; Maeda K; Berg RA; Kawut SM; Harhay MO; Goldfarb SB; Yehya N; Himebauch AS
J Heart Lung Transplant; 2023 May; 42(5):669-678. PubMed ID: 36639317
[TBL] [Abstract][Full Text] [Related]
6. Lung transplantation: chronic allograft dysfunction and establishing immune tolerance.
Gracon AS; Wilkes DS
Hum Immunol; 2014 Aug; 75(8):887-94. PubMed ID: 24979671
[TBL] [Abstract][Full Text] [Related]
7. Ventilatory capacity in CLAD is driven by dysfunctional airway structure.
Kerckhof P; Ambrocio GPL; Beeckmans H; Kaes J; Geudens V; Bos S; Willems L; Vermaut A; Vermant M; Goos T; De Fays C; Aversa L; Mohamady Y; Vanstapel A; Orlitová M; Van Slambrouck J; Jin X; Varghese V; Josipovic I; Boone MN; Dupont LJ; Weynand B; Dubbeldam A; Van Raemdonck DE; Ceulemans LJ; Gayan-Ramirez G; De Sadeleer LJ; McDonough JE; Vanaudenaerde BM; Vos R
EBioMedicine; 2024 Mar; 101():105030. PubMed ID: 38394744
[TBL] [Abstract][Full Text] [Related]
8. The nature of chronic rejection after lung transplantation: a murine orthotopic lung transplant study.
Heigl T; Kaes J; Aelbrecht C; Serré J; Yamada Y; Geudens V; Van Herck A; Vanstapel A; Sacreas A; Ordies S; Frick A; Saez Gimenez B; Van Slambrouck J; Beeckmans H; Acet Oztürk NA; Orlitova M; Vaneylen A; Claes S; Schols D; Vande Velde G; Schupp J; Kaminski N; Boesch M; Korf H; van der Merwe S; Dupont L; Vanoirbeek J; Godinas L; Van Raemdonck DE; Janssens W; Gayan-Ramirez G; Ceulemans LJ; McDonough JE; Verbeken EK; Vos R; Vanaudenaerde BM
Front Immunol; 2024; 15():1369536. PubMed ID: 38736881
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody formation in human and rat studies of chronic rejection and primary graft dysfunction.
Wilkes DS
Semin Immunol; 2012 Apr; 24(2):131-5. PubMed ID: 21925897
[TBL] [Abstract][Full Text] [Related]
10. Bronchiolitis obliterans.
King TE
Lung; 1989; 167(2):69-93. PubMed ID: 2494394
[TBL] [Abstract][Full Text] [Related]
11. Definitions of Dysbiosis in Chronic Lung Allograft Dysfunction and High Bacterial Biomass.
McGinniss J
Am J Respir Crit Care Med; 2024 Jun; 209(11):1296-1298. PubMed ID: 38536158
[No Abstract] [Full Text] [Related]
12. Outcome of lung transplantation in patients with pulmonary alveolar microlithiasis in the era of COVID-19 infection.
Raavi L; Garg P; Alomari M; Celik NB; Makey IA; Thomas M; Nassar A; Sareyyupoglu B; Jacob S; Pham SM; El-Sayed Ahmed MM
J Surg Case Rep; 2024 Apr; 2024(4):rjae211. PubMed ID: 38605700
[TBL] [Abstract][Full Text] [Related]
13. Prevention of bronchiolitis obliterans-the realization of a hope?
Cascalho M
J Heart Lung Transplant; 2017 Feb; 36(2):132-133. PubMed ID: 27667135
[No Abstract] [Full Text] [Related]
14. Using Functional Lung MRI to Predict Chronic Lung Allograft Dysfunction.
Fain SB; Schiebler ML
Radiology; 2023 May; 307(4):e230636. PubMed ID: 37070992
[No Abstract] [Full Text] [Related]
15. A new classification system for chronic lung allograft dysfunction.
Verleden GM; Raghu G; Meyer KC; Glanville AR; Corris P
J Heart Lung Transplant; 2014 Feb; 33(2):127-33. PubMed ID: 24374027
[TBL] [Abstract][Full Text] [Related]
16. Chronic Lung Allograft Dysfunction: A Systematic Review of Mechanisms.
Royer PJ; Olivera-Botello G; Koutsokera A; Aubert JD; Bernasconi E; Tissot A; Pison C; Nicod L; Boissel JP; Magnan A;
Transplantation; 2016 Sep; 100(9):1803-14. PubMed ID: 27257997
[TBL] [Abstract][Full Text] [Related]
17. Chronic lung allograft dysfunction phenotypes and treatment.
Verleden SE; Vos R; Vanaudenaerde BM; Verleden GM
J Thorac Dis; 2017 Aug; 9(8):2650-2659. PubMed ID: 28932572
[TBL] [Abstract][Full Text] [Related]
18. Impact of CLAD Phenotype on Survival After Lung Retransplantation: A Multicenter Study.
Verleden SE; Todd JL; Sato M; Palmer SM; Martinu T; Pavlisko EN; Vos R; Neyrinck A; Van Raemdonck D; Saito T; Oishi H; Keshavjee S; Greer M; Warnecke G; Gottlieb J; Haverich A
Am J Transplant; 2015 Aug; 15(8):2223-30. PubMed ID: 25940517
[TBL] [Abstract][Full Text] [Related]
19. Chronic lung allograft dysfunction: evolving practice.
Vos R; Verleden SE; Verleden GM
Curr Opin Organ Transplant; 2015 Oct; 20(5):483-91. PubMed ID: 26262458
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
